| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +30K | 100% | $1.03 | +$30.9K |
| Sells | 0 | ||||
| Net | +1 | +30K | 100% | +$30.9K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Michael J. Fox | Director | $3.04M | Jun 5, 2024 | ||
| Cameron Gray | Director | $1.9M | Jun 14, 2022 | ||
| Anish Suri | President And Cso | $374K | Jun 5, 2024 | ||
| Daniel Passeri | CHIEF EXECUTIVE OFFICER, Director | $170K | +$30.9K | +22.3% | Dec 16, 2024 |
| Patrick Verheyen | Director | $22.6K | Jan 2, 2024 | ||
| Peter Kiener | Director | $985 | Jan 2, 2024 | ||
| Frank Morich | Director | Jan 2, 2024 | |||
| Colin Sandercock | Svp, General Counsel | Jun 5, 2024 | |||
| Matteo Levisetti | Chief Medical Officer | Jun 5, 2024 | |||
| Pamela Garzone | Director | Jan 2, 2024 | |||
| Frederick Driscoll | Director | Jan 2, 2024 | |||
| Tamar Howson | Director | Jan 3, 2023 | |||
| Kenneth Pienta | Chief Medical Officer | Mar 25, 2022 | |||
| Daniel G. Baker | Chief Development Officer | Nov 25, 2024 | |||
| Lucinda Warren | Chief Business Officer | Sep 3, 2024 | |||
| Aaron G.L. Fletcher | Director | Jan 3, 2023 | |||
| Patricia Nasshorn | Chief Business Officer | Feb 16, 2023 | |||
| Kerri-Ann Millar | Chief Financial Officer | Jun 5, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|